Lab Chemical Companies Merge
The acquisition increases AppliChemi’s presence in the US market. Akron’s products join Applichem’s catalog of 4,000 products, which include enzyme inhibitors, enzymes, cell culture powder media and custom synthesized products.
Darmstadt, Germany 3/3/09; Boca Raton, FL 3/3/09—AppliChem GmbH and Akron Biotechnology have merged, with Akron Biotech taking over AppliChem’s operations in the Americas on March 2 and adopting the AppliChem name. AppliChem offers biochemicals and reagents. Akron Biotechnology manufactures stem cell culture products. Dr. Claudia Zylvberberg will remain president and CEO of AppliChem.
< Previous Article | Next Article >

